|
|
|
|
|
|
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期- |
A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
The objective of this study is to compare the efficacy and safety of RGN-137 topical gel with that of placebo gel for treatment of junctional epidermolysis bullosa (JEB) or dystrophic epidermolysis bullosa (DEB).
100 项与 Lenus Therapeutics, LLC 相关的临床结果
0 项与 Lenus Therapeutics, LLC 相关的专利(医药)
100 项与 Lenus Therapeutics, LLC 相关的药物交易
100 项与 Lenus Therapeutics, LLC 相关的转化医学